amotosalen has been researched along with interleukin-8 in 2 studies
| Studies (amotosalen) | Trials (amotosalen) | Recent Studies (post-2010) (amotosalen) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 179 | 18 | 103 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cimino, G; Corash, L; Grass, J; Hei, DJ; Lin, L | 1 |
| Arthaud, CA; Barlet-Excoffier, V; Bonneaudeau, B; Chavarin, P; Cognasse, F; Duchez, AC; Eyraud, MA; Hamzeh-Cognasse, H; Heestermans, M; Hequet, O; Legrand, D; Mooney, N; Morel, P; Prier, A; Richard, P; Rochette-Eribon, S; Shurko, N; Teyssier, F; Tiberghien, P | 1 |
2 other study(ies) available for amotosalen and interleukin-8
| Article | Year |
|---|---|
Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
Topics: Blood Preservation; Cytokines; Depression, Chemical; DNA Adducts; Enzyme-Linked Immunosorbent Assay; Ficusin; Furocoumarins; Gamma Rays; Gene Expression Regulation; Humans; Interleukin-8; Leukocytes; Methoxsalen; Platelet Transfusion; Radiation-Sensitizing Agents; Time Factors; Trioxsalen; Ultraviolet Rays | 1999 |
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Topics: COVID-19; COVID-19 Serotherapy; Endothelial Cells; Humans; Interleukin-10; Interleukin-18; Interleukin-1beta; Interleukin-6; Interleukin-8; Pandemics; Technology; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 2022 |